Synthesis and biological evaluation of cyclic sulfamide derivatives as 11β-hydroxysteroid dehydrogenase 1 inhibitors

Se Hoan Kim, Ju Han Bok, Jae Hong Lee, Il Hyang Kim, Sung Wook Kwon, Gui Bin Lee, Seung Kyu Kang, Ji Seon Park, Won Hoon Jung, Hee Yeon Kim, Sang Dal Rhee, Sung Hoon Ahn, Myung Ae Bae, Deok Chan Ha, Ki Young Kim, Jin Hee Ahn

    Research output: Contribution to journalArticlepeer-review

    23 Citations (Scopus)

    Abstract

    A new series of cyclic sulfamide derivatives were synthesized and evaluated for their ability to inhibit 11β-HSD1. Among this series, 18e showed good in vitro activity toward human 11β-HSD1, selectivity against 11β-HSD2, microsomal stability, and pharmacokinetic and safety profiles (hERG, CYP, and acute toxicity). Additionally, 18e exhibited good in vivo efficacy in rat and monkey models.

    Original languageEnglish
    Pages (from-to)88-93
    Number of pages6
    JournalACS Medicinal Chemistry Letters
    Volume3
    Issue number2
    DOIs
    Publication statusPublished - 2012 Feb 9

    Keywords

    • 11β-hydroxysteroid dehydrogenase type 1
    • adamantyl group
    • antidiabetic agents
    • cyclic sulfamide
    • diabetes

    ASJC Scopus subject areas

    • Biochemistry
    • Drug Discovery
    • Organic Chemistry

    Fingerprint

    Dive into the research topics of 'Synthesis and biological evaluation of cyclic sulfamide derivatives as 11β-hydroxysteroid dehydrogenase 1 inhibitors'. Together they form a unique fingerprint.

    Cite this